Serine/threonine-protein kinase haspin
Named enzymes, including the metabolising cytochromes and the monoamine oxidases.
- Measurements
- 5
- Compounds
- 1
- Binding constants
- 0
- Median pX
- —
I · Identity
What this target is
Its function as UniProt states it, where in a cell the protein is found, and which cell types and tissues transcribe its gene.
Serine/threonine-protein kinase haspin
Serine/threonine-protein kinase that phosphorylates histone H3 at 'Thr-3' (H3T3ph) during mitosis. May act through H3T3ph to both position and modulate activation of AURKB and other components of the chromosomal passenger complex (CPC) at centromeres to ensure proper chromatid cohesion, metaphase alignment and normal progression through the cell cycle
Quoted from UniProt’s FUNCTION annotation for Q8TF76 (reviewed).
What it acts with
STRING’s highest-confidence human functional partners. The combined score mixes several kinds of evidence, so each channel is shown separately — a partner supported by experiment is a different claim from one supported only by text mining, and for a receptor this is where its coupling appears as evidence rather than as assertion.
Where it sits in the cell
- Nucleoplasm
Human Protein Atlas, by antibody immunofluorescence in cell lines — a different assay from the expression figures below, which are RNA.
UniProt, curated Nucleus · Chromosome · Cytoplasm, cytoskeleton, spindle
Expression by cell type
Single cell type RNA, the 10 highest of those the Human Protein Atlas reports for this gene. Transcript, not protein, and a cell type rather than a tissue.
- Late primary spermatocytes34.1 nCPM
- Early spermatids17.2 nCPM
- Late spermatids9.7 nCPM
- Monocyte progenitors7.1 nCPM
- Megakaryocyte progenitors6.6 nCPM
- Erythrocyte progenitors5 nCPM
- Differentiating spermatogonia3.8 nCPM
- Early primary spermatocytes3.7 nCPM
- Extravillous trophoblasts3.6 nCPM
- Plasma cells3.4 nCPM
Expression by tissue
The tissues this gene is enriched in, by consensus RNA. A tissue absent from this list is one the Atlas does not call specific for this gene, which is not the same as absent from it.
- testis6.8 nTPM
- bone marrow5.7 nTPM
- lymphoid tissue5 nTPM
II · Anatomy
Where the gene is transcribed
The same two atlases the compound plates use, asked about this gene alone. Brain on the left, peripheral and autonomic tissues on the right.
Brain
basal ganglia: drawn as the caudate nucleus, putamen and globus pallidus.
Measured but not drawn — this anatomogram has no outline for them: spinal cord 0.1.
Body
Square-root ramp · shared scale across both plates
Shading is transcript level — not affinity, and not affinity combined with expression. Outlined but unshaded organs hold none of HASPIN transcript above the atlas’s detection threshold. Anatomy from EMBL-EBI Anatomogram (Apache License 2.0); regions identified by Uberon (uberon.org), CC BY 3.0.
Brain · 2
- cerebral cortex0.1 nTPM
- spinal cord0.1 nTPM
Peripheral and autonomic · 15
- small intestine1.7 nTPM
- spleen1.6 nTPM
- duodenum1.4 nTPM
- lung1.3 nTPM
- colon1.0 nTPM
- stomach 10.9 nTPM
- skeletal muscle0.5 nTPM
- salivary gland0.4 nTPM
- smooth muscle0.3 nTPM
- thyroid gland0.3 nTPM
- urinary bladder0.3 nTPM
- heart muscle0.1 nTPM
- liver0.1 nTPM
- adrenal gland0.1 nTPM
- pancreas0.1 nTPM
Transcript is not protein. These are RNA levels for HASPIN, shaded on √nTPM so that a three-order range stays legible — on a linear ramp every region but the strongest would read as blank, which looks like absence rather than less. A region carrying no shading is one the atlas reports no consensus value for, not one where the gene is silent. And a gene being transcribed somewhere is not evidence that any compound reaches it. Human Protein Atlas, RNA expression, nTPM (normalized transcripts per million), consensus tissue dataset.
IV · Evidence
Every measurement at this target
Each row links to the ChEMBL assay it came from.
Functional readouts 3
IC₅₀, EC₅₀, AC₅₀ and potency. Assay-dependent, and not interchangeable with a binding constant.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Serine/threonine-protein kinase haspin | Enzymes | IC50 | 590 | 6.23 | Homo sapiens | CHEMBL2014113 |
| Serine/threonine-protein kinase haspin | Enzymes | IC50 | 590 | 6.23 | Homo sapiens | CHEMBL5242305 |
| Serine/threonine-protein kinase haspin | Enzymes | IC50 | 590 | 6.23 | Homo sapiens | CHEMBL5553823 |
Other measurements 2
Everything else ChEMBL recorded for this compound — percentage inhibition, efficacy, half-life, cytotoxicity. Reported in the assay's own units, which is why no value is converted here.
| Target | Class | Type | Value (nM) | pX | Organism | Assay |
|---|---|---|---|---|---|---|
| Serine/threonine-protein kinase haspin | Enzymes | Activity | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL4151464 |
| Serine/threonine-protein kinase haspin | Enzymes | Activity | — no normalized value | — value does not convert to pX | Homo sapiens | CHEMBL4344403 |